Examples of 'myelodysplastic' in a sentence
Meaning of "myelodysplastic"
myelodysplastic (adjective) - Myelodysplastic is a medical term used to describe disorders or conditions related to abnormal development or production of blood cells in the bone marrow
Show more definitions
- Of, pertaining to, or showing evidence of myelodysplasia
How to use "myelodysplastic" in a sentence
Basic
Advanced
myelodysplastic
Myelodysplastic syndrome and acute myeloid leukaemia.
A hematological cancer can be a myelodysplastic syndrome or a leukemia.
Myelodysplastic syndrome refers to a range of blood disorders.
Hematological cancers can be myelodysplastic syndromes or leukemias.
Myelodysplastic syndrome can affect people of all ages.
You have something called myelodysplastic syndrome.
Treating myelodysplastic syndrome in a patient in need thereof.
Patients with myeloid leukaemia or myelodysplastic syndromes.
Myelodysplastic syndrome is a premalignant disease that affects myeloid cell.
There may also be transformation to myelodysplastic syndrome.
Myelodysplastic syndroma and acute leukemia are characterized by a pathological hematopoieisis.
Use in adult patients with myelodysplastic syndrome.
He had myelodysplastic syndrome.
Compositions for use in treating myelodysplastic syndrome.
Myelodysplastic syndromes involve ineffective production of one or more cell lines.
See also
Algorithm applied for myelodysplastic syndromes.
Myelodysplastic syndrome is sometimes also called myelodysplasia dysmyelopoiesis or oligoblastic leukemia.
The hematological cancer can be myelodysplastic syndromes or leukemias.
People with myelodysplastic syndromes often need transfusions of red blood cells.
Acute myeloid leukemia with prior myelodysplastic syndrome.
Myelodysplastic syndromes can progress to acute myeloid leukemia in about one third of people.
One subject had myelodysplastic syndrome.
Lenalidomide is an anti cancer drug useful in the treatment of myelodysplastic syndrome.
It is the process by which myelodysplastic syndrome can be reversed.
Both azacitidine and decitabine are used in the treatment of myelodysplastic syndrome.
No patient was diagnosed with myelodysplastic syndrome in either treatment groups.
Malignant diseases including multiple myeloma and myelodysplastic syndrome.
Treatment of myelodysplastic syndromes.
Cancer patients including adult patients with myelodysplastic syndrome.
Myelodysplastic syndrome is also included in leukemia because of its similarity and correlation in findings.
Treatment of high or very high risk myelodysplastic syndromes.
Myelodysplastic diseases such as polycythemia vera have already been reported as associated with the syndrome.
Adverse events reported as serious in myelodysplastic syndromes clinical trials.
His clinical work focuses on the care of patients with myeloproliferative neoplasms and myelodysplastic syndrome.
Current treatment outcomes for the myelodysplastic syndromes have been disappointing.
This chromosome abnormality is most commonly associated with the myelodysplastic syndrome.
The risk group for the development of myelodysplastic syndrome is mainly elderly patients.
In another aspect the cancer to be treated is a haematological cancer such as myelodysplastic syndrome.
In anaemic adult patients with myelodysplastic syndrome to reduce the need for a blood transfusion.
Any foregoing method wherein the anemia is of myelodysplastic origin.
Myelodysplastic syndromes occur when something disrupts this process so that the blood cells do not mature.
Transformation to leukaemia or myelodysplastic syndrome.
The presence of myelodysplastic features characteristic of MDS was evaluated by experienced hematopathologist.
Any foregoing method wherein the cancer is myelodysplastic syndrome.
Myelodysplastic syndrome or Chronic myeloid leukaemia.
The total score is used to assign the myelodysplastic syndrome a risk category.
There are specific genetic conditions and specific genes involved which are responsible for myelodysplastic syndrome.
Progression of existing myelodysplastic syndrome MDS.
This group includes those patients previously diagnosed with a myeloproliferative or myelodysplastic syndrome.
Myelodysplastic syndrome or Chronic myeloid leukemia.
